Moreover, the immunosuppressive cytokine IL-10 was downregulated upon anti-IL-9 treatment (Figure 9J), suggesting that IL-9 controls the balance between inflammatory and immunosuppressive cytokines in NSCLC. Here, IL9 is linked to non-small cell lung carcinoma.